CITING SUPPLY-CHAIN ruptionsand prior hikes in raw Fric materials of critical drugs, the Narsonal Pharmaceutical ing Authority (NPJon Friday reason its prior citrul no and alloseed drug eng to substantially ratte prer a set of enential cancer Uruga and vaccines. The regulator said the higher prices are nec essary for the continued pro duction and uninterrupted supply of these critical thera-pies.
Thmugh its extraordinary powers under Paragragih 19 of the Drug Pricne Control Order, 2013, the NPPA allowed a one time 50% increase in ceiling prices of two cancer drugs carboplatinand cuplatin-ing sharp increases in their active pharmaceutical ingredi ent (AP) prices in recent years and currency exchange rates. Pfizer, Cipla, Allen, and Zydus Healthcare are among the firms that sell theun medicines In India
Satinder Duggal
